
Trump’s Top Lawyer at FDA Resigns After Outcry Over Record Defending Abortion Pill
Here is a roundup of recent pro-life and abortion-related news.
Here is a roundup of recent pro-life and abortion-related news.
The report by the American Life League criticizes government officials for doing little to stop a pro-abortion ‘cartel’ from shipping pills to states that ban or regulate access to abortion.
COMMENTARY: An educated public remains the best defense against the FDA’s reckless actions.
EDITORIAL: Ultimately, our faith — when it comes to bringing an to end to legal abortion — shouldn’t rest in any branch of government.
The USCCB was part of an amicus brief with 10 other pro-life organizations, including Susan B. Anthony Pro-Life America, Catholic Health Care Leadership Alliance, and the Catholic Bar Association.
Abortion pills are a potential election issue this fall and beyond.
Pro-life House members are urging the high court to restore what they believe are necessary restrictions on the abortion drug known as mifepristone.
EDITORIAL: For the abortion lobby as a whole, ‘conflict-of-interest’ considerations can arise in only one direction.
Casgevy is a new treatment for sickle cell disease, a blood disorder that affects approximately 100,000 Americans.
They echo other critics who say the drug’s side effects mean patients should have physician supervision while taking the drug.
Subscriber Service CenterAlready a subscriber? Renew or manage your subscription here.
Subscribe for just $49.95 $32.50!Start your Register subscription today.
Give a Gift SubscriptionBless friends, family or clergy with a gift of the Register.
Order NowOrder Bulk SubscriptionsGet a discount on 6 or more copies sent to your parish, organization or school.
Order NowSign-up for E-NewsletterGet Register Updates sent daily or weeklyto your inbox.
Sign Up